Diagnostic and treatment concerns in familial Mediterranean fever

被引:137
作者
Livneh, A [1 ]
Langevitz, P
机构
[1] Chaim Sheba Med Ctr, Heller Inst Med Res, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Dept Med F, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Rheumatol Unit, IL-52621 Tel Hashomer, Israel
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2000年 / 14卷 / 03期
关键词
familial Mediterranean fever; periodic febrile syndromes; colchicine; amyloidosis; diagnostic criteria;
D O I
10.1053/berh.2000.0089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial Mediterranean fever (FMF) is an autosomal, recessively inherited disease, affecting people of Jewish, Arabic, Turkish and Armenian ancestry. The disease is the prototype of the period ic febrile syndromes. Its hallmark is short attacks of fever and painful manifestations in the abdomen, joints, chest, scrotum and skin. Chronic and protracted manifestations, particularly nephropathic amyloidosis, chronic arthritis, and protracted myalgia, may also occur in the disease. The diagnosis of FMF should be considered in individuals of an appropriate ethnic background who present with febrile disease of episodic nature. The differential diagnosis in this case is broad and includes a large number of infectious, inflammatory and genetic diseases. However, in most cases, the very specific general and site-restricted features of the FMF attacks on the one hand, and the absence of manifestations typical of other conditions on the other hand, determine the diagnosis of FMF. This chapter presents clues and tips that help in the diagnosis and treatment of FMF.
引用
收藏
页码:477 / 498
页数:22
相关论文
共 69 条
[1]   Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population [J].
Aksentijevich, I ;
Torosyan, Y ;
Samuels, J ;
Centola, M ;
Pras, E ;
Chae, JJ ;
Oddoux, C ;
Wood, G ;
Azzaro, MP ;
Palumbo, G ;
Giustolisi, R ;
Pras, M ;
Ostrer, H ;
Kastner, DL .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (04) :949-962
[2]  
Aksentijevich I, 1997, CELL, V90, P797
[3]  
BARZILAI A, IN PRESS J AM ACAD D
[4]   Colchicine: 1998 update [J].
Ben-Chetrit, E ;
Levy, M .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 28 (01) :48-59
[5]   COLCHICINE PROPHYLAXIS IN FAMILIAL MEDITERRANEAN FEVER - REAPPRAISAL AFTER 15 YEARS [J].
BENCHETRIT, E ;
LEVY, M .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1991, 20 (04) :241-246
[6]   Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF) [J].
Bernot, A ;
da Silva, C ;
Petit, JL ;
Cruaud, C ;
Caloustian, C ;
Castet, V ;
Ahmed-Arab, M ;
Dross, C ;
Dupont, M ;
Cattan, D ;
Smaoui, N ;
Dodé, C ;
Pêcheux, C ;
Nédelec, B ;
Medaxian, J ;
Rozenbaum, M ;
Rosner, I ;
Delpech, M ;
Grateau, G ;
Demaille, J ;
Weissenbach, J ;
Touitou, I .
HUMAN MOLECULAR GENETICS, 1998, 7 (08) :1317-1325
[7]  
Bernot A, 1997, NAT GENET, V17, P25
[8]   Pyrin/marenostrin mutations in familial Mediterranean fever [J].
Booth, DR ;
Gillmore, JD ;
Booth, SE ;
Pepys, MB ;
Hawkins, PN .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1998, 91 (09) :603-606
[9]  
BUSKILA D, 1997, CLIN EXPT RHEUMATOLO, V15, P55
[10]   MEFV-gene analysis in Armenian patients with familial Mediterranean fever:: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype -: Genetic and therapeutic implications [J].
Cazeneuve, C ;
Sarkisian, T ;
Pêcheux, C ;
Dervichian, M ;
Nédelec, B ;
Reinert, P ;
Ayvazyan, A ;
Kouyoumdjian, JC ;
Ajrapetyan, H ;
Delpech, M ;
Goossens, M ;
Dodé, C ;
Grateau, G ;
Amselem, S .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) :88-97